Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Sumoylation pathway is required to maintain the basal breast cancer subtype

Class:Id	LiteratureReference:8874763
_displayName	Sumoylation pathway is required to maintain the basal breast cancer subtype
_timestamp	2016-05-27 18:29:56
author	[Person:8874767] Bogachek, Maria V [Person:8874769] Chen, Yizhen [Person:8874780] Kulak, Mikhail V [Person:8874775] Woodfield, George W [Person:8874757] Cyr, Anthony R [Person:8874779] Park, Jung M [Person:8874777] Spanheimer, Philip M [Person:8874761] Li, Yingyue [Person:8874760] Li, Tiandao [Person:8864570] Weigel, Ronald J
created	[InstanceEdit:8874781] Orlic-Milacic, Marija, 2016-05-27
journal	Cancer Cell
pages	748-61
pubMedIdentifier	24835590
title	Sumoylation pathway is required to maintain the basal breast cancer subtype
volume	25
year	2014
(literatureReference)	[Reaction:3234081] SUMOylation of TFAP2A with SUMO1 [Homo sapiens] [Pathway:8864260] Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors [Homo sapiens] [Pathway:8866904] Negative regulation of activity of TFAP2 (AP-2) family transcription factors [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by Sumoylation pathway is required to maintain the basal breast cancer subtype (8874763)